Verified investment lower bound≥$20.33M
Investment cases2
Manager operating history—
Representative investments
Individual transactions and cumulative snapshots use different bases. Do not add these rows again to cumulative totals.
| Date | Company | Round | Original-currency amount | Paying entity | Specific funds | Sources |
|---|---|---|---|---|---|---|
| 2026-01-09 | MiniMax | IPO基石获配 | HKD 155.61M | Mirae Asset Securities | — | Sources · 1
Basis and notes最终获配943,080股 × 165港元/股；计算值，不含佣金、征费及超额配售。仅本次IPO认购，非该机构全部历史投入；最终配发结果并非逐笔银行到账证明。 |
| 2025-12-30 | Insilico Medicine（英矽智能） | IPO最终获配认购 | HKD 3.85M | Mirae Asset Securities Co., Ltd. | — | Sources · 2
Basis and notes基石0股＋额外国际配售160,000股，合计160,000股×HK$24.05。按最终配售计算认购款，不含费用，不声称银行流水已核。上市日为交易事件日期，非银行付款日。美元仅使用本站既有汇率快照；不是按当前股价计算。 |